Pneumonia News and Research

Latest Pneumonia News and Research

Google search data could predict new COVID-19 cases

Researchers showed that Google search data could be utilized for monitoring the spread of COVID-19 cases.

27 Apr 2022

Evidence of accelerated epigenetic age in SARS-CoV-2-positive patients

Researchers assessed the epigenetic aging in COVID-19 patients and its impact on COVID-19 severity by a genome-wide deoxyribonucleic acid methylation profiling analysis.

27 Apr 2022

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

As part of World Immunization Week 2022, News Medical speaks to Thabani Maphosa, the Managing Director of Country Programmes at Gavi, The Vaccine Alliance, about their work to increase equitable and sustainable use of vaccines by maximizing financial investments, bringing the best partners to the table and driving innovation.

27 Apr 2022

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

T cell responses were measured to three SARS-CoV-2-associated antigens, as well as the endemic coronaviruses HCoV-OC43 and HCoV-NL63.

25 Apr 2022

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be on the horizon, after identifying two proteins that are critical to the survival of the malaria parasite, Plasmodium falciparum.

25 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

Research identifies the third day of hospitalization as a tipping point in progression of COVID-19 pneumonia

New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal, (23-26 April), has identified the third day of hospitalization as a tipping point in the progression of disease among symptomatic patients admitted for COVID-19 pneumonia.

23 Apr 2022

Disease-causing amoebas that live on organic leafy vegetables could be a threat to public health

New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April), suggests that disease-causing amoebas that live on organic leafy vegetables can shelter human pathogens like Pseudomonas, Salmonella, and Helicobacter and are a potential risk to public health.

23 Apr 2022

Nurseries, schools, nursing homes and other indoor settings exposed to high levels of respiratory pathogens during winter

High levels of respiratory pathogens are present in the air of nurseries, schools, nursing homes and other indoor settings during winter, according to new research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal, (23-26 April).

23 Apr 2022

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Researchers reported that plasma IL-6 levels in patients with ARDS due to COVID-19 could predict early withdrawal from mechanical ventilation.

22 Apr 2022

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Researchers investigate the rates at which different pathogens appear in children, both independently and alongside SARS-CoV-2.

21 Apr 2022

Study finds higher risk of dementia among patients hospitalized with COVID-19 pneumonia

A new study from the from the University of Missouri School of Medicine and MU Health Care shows patients hospitalized with COVID-19 pneumonia have a higher risk of developing dementia than those with other types of pneumonia.

19 Apr 2022

Vertical transmission of SARS-CoV-2 uncommon

A new study shows that SARS-CoV-2 infection is not typically transferred to newborns from infected mothers, and if such transmission occurs, the resulting disease is usually mild.

19 Apr 2022

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

For two years now, the novel coronavirus SARS-CoV-2 has ravaged populations the world over. Some researchers believe that the virus will mutate toward less harmless variants.

19 Apr 2022

Why cheap, older drugs that might treat covid never get out of the lab

In March 2020, Dr. Joseph Vinetz left the contemplative world of his Yale University infectious-disease laboratory and plunged into the covid ward at Yale New Haven Hospital, joining an army of health care workers who struggled to treat the deadly viral disease.

19 Apr 2022

New, longest documented case of persistent acute SARS-CoV-2 infection

Researchers describe a 16-month-old case of SARS-CoV-2 infection in an immunocompromised individual.

18 Apr 2022

Pod-based e-cigarette use alters the inflammatory state across multiple organ systems

Researchers at University of California San Diego School of Medicine report that daily use of pod-based e-cigarettes alters the inflammatory state across multiple organ systems including the brain, heart, lungs and colon. Effects also vary depending on the e-cigarette flavor, and can influence how organs respond to infections, such as SARS-CoV-2.

13 Apr 2022

New study reveals oral opaganib's potent in vitro activity against Omicron

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced study results in which opaganib (ABC294640), a leading oral drug candidate for hospitalized patients with moderate to severe COVID-19, was observed to have potent in vitro efficacy against the Omicron SARS-CoV-2 variant, while maintaining host cell viability.

11 Apr 2022

COVID-19 increases risk of bleeding, DVT, and pulmonary embolism

...

11 Apr 2022

International study offers insight into occurrence of acute myocarditis during COVID-19 hospitalization

Acute myocarditis, inflammation of the heart muscle typically triggered by a virus, occurred in about two out of every 1,000 people hospitalized with COVID-19, and was associated with more severe illness and complications in people with COVID-19, especially among people who also had pneumonia, according to new research published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

11 Apr 2022

Pneumonia News and Research

Latest Pneumonia News and Research

Google search data could predict new COVID-19 cases

Evidence of accelerated epigenetic age in SARS-CoV-2-positive patients

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

The challenges of Omicron

Research identifies the third day of hospitalization as a tipping point in progression of COVID-19 pneumonia

Disease-causing amoebas that live on organic leafy vegetables could be a threat to public health

Nurseries, schools, nursing homes and other indoor settings exposed to high levels of respiratory pathogens during winter

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Study finds higher risk of dementia among patients hospitalized with COVID-19 pneumonia

Vertical transmission of SARS-CoV-2 uncommon

NTNU researcher explores how kids are affected by coronavirus, RS virus and rhinovirus

Why cheap, older drugs that might treat covid never get out of the lab

New, longest documented case of persistent acute SARS-CoV-2 infection

Pod-based e-cigarette use alters the inflammatory state across multiple organ systems

New study reveals oral opaganib's potent in vitro activity against Omicron

COVID-19 increases risk of bleeding, DVT, and pulmonary embolism

International study offers insight into occurrence of acute myocarditis during COVID-19 hospitalization

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Pneumonia News and Research

Latest Pneumonia News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in